Assessment Protocol for Incidental Erythrocytosis
The evaluation of an incidental finding of high red blood cell count (erythrocytosis) with elevated hematocrit, hemoglobin, and high red cell distribution width should follow a systematic diagnostic approach to determine if it represents true erythrocytosis and identify the underlying cause.
Initial Laboratory Evaluation
- The minimum workup should include complete blood count with red cell indices (MCV, RDW), reticulocyte count, differential blood cell count, serum ferritin, transferrin saturation, and C-reactive protein (CRP) 1
- Assess for true versus relative polycythemia by confirming elevated hemoglobin (>18.5 g/dL in men, >16.5 g/dL in women) or hematocrit (>55% in men, >49.5% in women) 1
- High RDW with normal or low MCV suggests possible iron deficiency coexisting with erythrocytosis 1
- Evaluate for dehydration as a potential cause of relative polycythemia by reviewing clinical signs and obtaining history of fluid intake and losses 2
Secondary Evaluation Based on Erythropoietin Level
- Measure serum erythropoietin (EPO) level to differentiate between primary and secondary causes 3
- Low EPO suggests primary erythrocytosis (e.g., polycythemia vera) 3
- Normal or elevated EPO indicates secondary erythrocytosis 3
Testing for Primary Erythrocytosis
- For suspected polycythemia vera (PV), test for JAK2 mutations (both exon 14 and exon 12) 1
- According to WHO criteria, PV diagnosis requires either:
- Both major criteria (elevated hemoglobin/hematocrit/RBC mass AND presence of JAK2 mutation) plus at least one minor criterion, OR
- First major criterion plus at least two minor criteria 1
- Minor criteria include MPD-consistent bone marrow histology, serum erythropoietin level below reference range, and presence of endogenous erythroid colonies 1
Testing for Secondary Erythrocytosis
- Extended workup for normal/high EPO cases should include:
- Arterial blood gas analysis to assess for hypoxemia 3
- Overnight oximetry to evaluate for sleep apnea 3
- Abdominal imaging (ultrasound or CT) to rule out renal or hepatic tumors 3
- Genetic testing for congenital causes in younger patients or those with family history, including VHL, PHD2, and HIF2A mutations 4, 5
Additional Considerations
- Assess for iron deficiency which may mask the degree of erythrocytosis - iron studies should include serum ferritin, iron, TIBC, and transferrin saturation 1
- Evaluate vitamin B12 and folate levels if macrocytosis is present 1
- Consider bone marrow examination if diagnosis remains unclear after initial testing 3
Management Approach
- For patients with confirmed true erythrocytosis, the diagnostic pathway should be guided by erythropoietin levels, with subsequent testing tailored to distinguish between primary and secondary causes 3
- Therapeutic phlebotomy should be considered only if hemoglobin is greater than 20 g/dL and hematocrit greater than 65%, with associated symptoms of hyperviscosity 1
- Repeated routine phlebotomies should be avoided due to risk of iron depletion, decreased oxygen-carrying capacity, and stroke 1
- If iron deficiency is confirmed in the context of erythrocytosis, cautious iron supplementation with close monitoring of hemoglobin levels is recommended 1
Follow-up Recommendations
- Repeat CBC after ensuring adequate hydration if relative polycythemia is suspected 2
- For patients with unexplained erythrocytosis after standard evaluation, consider referral to a hematologist for further specialized testing 6
- Gene panel sequencing may be beneficial for patients with idiopathic erythrocytosis, as it can identify mutations missed by traditional sequential testing approaches 5